Suchbegriffe: EXERCISE TOLERANCE - DRUG EFFECTS , . Treffer: 16
Edelmann, F; Gelbrich, G; Duvinage, A; Stahrenberg, R; Behrens, A; Prettin, C; Kraigher-Krainer, E; Schmidt, AG; Düngen, HD; Kamke, W; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
Int J Cardiol. 2013; 169(6):408-417
Doi: 10.1016/j.ijcard.2013.10.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ghofrani, HA; D'Armini, AM; Grimminger, F; Hoeper, MM; Jansa, P; Kim, NH; Mayer, E; Simonneau, G; Wilkins, MR; Fritsch, A; Neuser, D; Weimann, G; Wang, C; CHEST-1 Study Group
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
N Engl J Med. 2013; 369(4):319-329
Doi: 10.1056/NEJMoa1209657
Web of Science
PubMed
FullText
FullText_MUG
Ghofrani, HA; Galiè, N; Grimminger, F; Grünig, E; Humbert, M; Jing, ZC; Keogh, AM; Langleben, D; Kilama, MO; Fritsch, A; Neuser, D; Rubin, LJ; PATENT-1 Study Group
Riociguat for the treatment of pulmonary arterial hypertension.
N Engl J Med. 2013; 369(4):330-340
Doi: 10.1056/NEJMoa1209655
Web of Science
PubMed
FullText
FullText_MUG
Conraads, VM; Metra, M; Kamp, O; De Keulenaer, GW; Pieske, B; Zamorano, J; Vardas, PE; Böhm, M; Dei Cas, L
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
EUR J HEART FAIL. 2012; 14(2): 219-225.
Doi: 10.1093/eurjhf/hfr161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
von Haehling, S; Schefold, JC; Jankowska, EA; Springer, J; Vazir, A; Kalra, PR; Sandek, A; Fauler, G; Stojakovic, T; Trauner, M; Ponikowski, P; Volk, HD; Doehner, W; Coats, AJ; Poole-Wilson, PA; Anker, SD
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
J Am Coll Cardiol. 2012; 59(6): 585-592.
Doi: 10.1016/j.jacc.2011.10.880
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Antoncic-Svetina, M; Sentija, D; Cipak, A; Milicic, D; Meinitzer, A; Tatzber, F; Andrisic, L; Zelzer, S; Zarkovic, N
Ergometry induces systemic oxidative stress in healthy human subjects.
Tohoku J Exp Med. 2010; 221(1):43-48
Doi: 10.1620/tjem.221.43
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Schmidt, AG; Gelbrich, G; Binder, L; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).
Eur J Heart Fail. 2010; 12(8):874-882
Doi: 10.1093/eurjhf/hfq087
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
McLaughlin, VV; Benza, RL; Rubin, LJ; Channick, RN; Voswinckel, R; Tapson, VF; Robbins, IM; Olschewski, H; Rubenfire, M; Seeger, W
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
J AMER COLL CARDIOL. 2010; 55(18): 1915-1922.
Doi: 10.1016/j.jacc.2010.01.027
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Oudiz, RJ; Galie, N; Olschewski, H; Torres, F; Frost, A; Ghofrani, HA; Badesch, DB; McGoon, MD; McLaughlin, VV; Roecker, EB; Harrison, BC; Despain, D; Dufton, C; Rubin, LJ
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.
J AMER COLL CARDIOL. 2009; 54(21): 1971-1981.
Doi: 10.1016/j.jacc.2009.07.033
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Parthasarathy, HK; Pieske, B; Weisskopf, M; Andrews, CD; Brunel, P; Struthers, AD; MacDonald, TM
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction
Eur J Heart Fail. 2009; 11(10):980-989
Doi: 10.1093/eurjhf/hfp120
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pokan, R; Hofmann, P; von Duvillard, SP; Smekal, G; Wonisch, M; Lettner, K; Schmid, P; Shechter, M; Silver, B; Bachl, N
Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients.
Br J Sports Med. 2006; 40(9):773-778
Doi: 10.1136/bjsm.2006.027250
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Galié, N; Badesch, D; Oudiz, R; Simonneau, G; McGoon, MD; Keogh, AM; Frost, AE; Zwicke, D; Naeije, R; Shapiro, S; Olschewski, H; Rubin, LJ
Ambrisentan therapy for pulmonary arterial hypertension.
J Am Coll Cardiol. 2005; 46(3):529-535
Doi: 10.1016/j.jacc.2005.04.050
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ghofrani, HA; Reichenberger, F; Kohstall, MG; Mrosek, EH; Seeger, T; Olschewski, H; Seeger, W; Grimminger, F
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ann Intern Med. 2004; 141(3):169-177
Doi: 10.7326/0003-4819-141-3-200408030-00005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Olschewski, H; Simonneau, G; Galiè, N; Higenbottam, T; Naeije, R; Rubin, LJ; Nikkho, S; Speich, R; Hoeper, MM; Behr, J; Winkler, J; Sitbon, O; Popov, W; Ghofrani, HA; Manes, A; Kiely, DG; Ewert, R; Meyer, A; Corris, PA; Delcroix, M; Gomez-Sanchez, M; Siedentop, H; Seeger, W; Aerosolized Iloprost Randomized Study Group
Inhaled iloprost for severe pulmonary hypertension.
N Engl J Med. 2002; 347(5):322-329
Doi: 10.1056/NEJMoa020204
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zarzeczny, R; Langfort, J; Pilis, W; Nazar, K; Kaciuba-Uscilko, H; Porta, S
Effect of sustained adrenergic receptors stimulation and blockade on lactate threshold in rats.
J Sports Med Phys Fitness. 2001; 41(3):324-329
Web of Science
PubMed
Olschewski, H; Ghofrani, HA; Schmehl, T; Winkler, J; Wilkens, H; Höper, MM; Behr, J; Kleber, FX; Seeger, W
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
Ann Intern Med. 2000; 132(6):435-443
Doi: 10.7326/0003-4819-132-6-200003210-00003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG